Scientists have developed AI-based system that can predict wheat yields early and with high accuracy using handheld field ...

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a ...

New research shows that the application of AI remains uneven across the full spectrum of disaster management, with most systems still concentrated on detection and prediction rather than actionable ...

To use this evidence, investigators typically must grow the larvae until adulthood in a laboratory setting and then identify ...

Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat the untreatable, today announced that together with Western ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...

The simulator takes into account forecasted demand in each region, transportation costs, and the operational capacity of each ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and projected to reach US$ 1,081.9 million ...